Advances in molecular characterization of pediatric acute megakaryoblastic leukemia not associated with Down syndrome; impact on therapy development.
acute megakaryoblastic leukemia (AMKL)
acute myeloid leukemia
chimeric fusions
cytogenetics
genomics
non-Down syndrome AMKL
therapeutic targets
transcriptomics
Journal
Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250
Informations de publication
Date de publication:
2023
2023
Historique:
received:
21
02
2023
accepted:
19
05
2023
medline:
16
6
2023
pubmed:
16
6
2023
entrez:
16
6
2023
Statut:
epublish
Résumé
Acute megakaryoblastic leukemia (AMKL) is a rare subtype of acute myeloid leukemia (AML) in which leukemic blasts have megakaryocytic features. AMKL makes up 4%-15% of newly diagnosed pediatric AML, typically affecting young children (less than 2 years old). AMKL associated with Down syndrome (DS) shows
Identifiants
pubmed: 37325571
doi: 10.3389/fcell.2023.1170622
pii: 1170622
pmc: PMC10267407
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1170622Informations de copyright
Copyright © 2023 Li and Kalev‐Zylinska.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Blood. 2009 Mar 19;113(12):2826-34
pubmed: 19136660
Stem Cells Int. 2018 Jul 22;2018:3569493
pubmed: 30154863
Front Genet. 2022 Aug 10;13:891214
pubmed: 36035173
Blood. 2009 Sep 3;114(10):2087-96
pubmed: 19542301
Clin Lymphoma Myeloma Leuk. 2021 Apr;21(4):e301-e308
pubmed: 33257285
Crit Rev Oncol Hematol. 2019 Jun;138:132-138
pubmed: 31092368
Leuk Lymphoma. 2019 Apr;60(4):1083-1086
pubmed: 30277109
Blood. 2015 Aug 20;126(8):943-9
pubmed: 26186939
Blood Adv. 2019 Nov 12;3(21):3307-3321
pubmed: 31698461
J Biol Chem. 2021 Jan-Jun;296:100543
pubmed: 33722605
Leukemia. 2022 Jul;36(7):1703-1719
pubmed: 35732831
Mol Cell Biol. 2007 Apr;27(8):3056-64
pubmed: 17283045
Cancers (Basel). 2021 Sep 26;13(19):
pubmed: 34638301
Eur J Haematol. 2009 Aug;83(2):149-53
pubmed: 19459927
Stem Cells Int. 2017;2017:6301385
pubmed: 29358956
Blood. 2018 Apr 19;131(16):1833-1845
pubmed: 29371181
J Hematol Oncol. 2017 Jan 21;10(1):26
pubmed: 28109323
Cancer Cell. 2012 Nov 13;22(5):683-97
pubmed: 23153540
Cancer Cell. 2016 Jul 11;30(1):43-58
pubmed: 27344946
PLoS One. 2012;7(8):e42965
pubmed: 22927943
Stem Cell Res. 2017 Mar;19:1-5
pubmed: 28412998
Genes (Basel). 2021 Jun 17;12(6):
pubmed: 34204358
Cancer Discov. 2019 Dec;9(12):1736-1753
pubmed: 31662298
Leukemia. 2008 Nov;22(11):2041-7
pubmed: 18668134
J Cell Physiol. 2018 Dec;233(12):9584-9593
pubmed: 30132837
Genes Chromosomes Cancer. 2022 Aug;61(8):491-496
pubmed: 35294081
Blood Adv. 2018 Oct 23;2(20):2691-2703
pubmed: 30337297
Trends Cancer. 2019 Sep;5(9):547-557
pubmed: 31474360
Leukemia. 2013 Dec;27(12):2280-8
pubmed: 23531517
Exp Ther Med. 2018 Mar;15(3):2563-2568
pubmed: 29456659
Stem Cell Investig. 2017 Sep 27;4:80
pubmed: 29057252
J Clin Invest. 2020 Feb 3;130(2):981-997
pubmed: 31855575
Cancers (Basel). 2021 Aug 18;13(16):
pubmed: 34439298
Blood. 2002 Jul 15;100(2):618-26
pubmed: 12091356
Br J Haematol. 2020 Feb;188(4):528-539
pubmed: 31612466
Leukemia. 2017 Jun;31(6):1269-1277
pubmed: 27840424
J Hematol Oncol. 2021 Apr 6;14(1):56
pubmed: 33823889
Curr Hematol Malig Rep. 2016 Oct;11(5):333-41
pubmed: 27510823
Sci Adv. 2022 Feb 11;8(6):eabg9455
pubmed: 35138899
Front Mol Biosci. 2022 Feb 09;9:842833
pubmed: 35223996
Blood Adv. 2020 Oct 13;4(19):4623-4631
pubmed: 32991719
Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):521-526
pubmed: 29056538
Nat Cancer. 2022 May;3(5):595-613
pubmed: 35534777
Genes Chromosomes Cancer. 2006 May;45(5):437-46
pubmed: 16419055
J Clin Oncol. 2021 Oct 1;39(28):3149-3160
pubmed: 34048275
Clin Lymphoma Myeloma Leuk. 2019 Mar;19(3):e142-e152
pubmed: 30686774
J Exp Med. 2012 Oct 22;209(11):2017-31
pubmed: 23045605
Genes Chromosomes Cancer. 2017 May;56(5):394-404
pubmed: 28063190
Haematologica. 2021 Apr 01;106(4):1106-1119
pubmed: 32527952
Blood. 2023 Mar 30;141(13):1610-1625
pubmed: 36508699
Haematologica. 2015 May;100(5):575-84
pubmed: 25682601
Cell Rep. 2016 May 10;15(6):1228-41
pubmed: 27134169
Mol Cell Biol. 2006 Aug;26(15):5809-26
pubmed: 16847333
Blood Cancer J. 2022 Jan 11;12(1):5
pubmed: 35017466
Cancer Med. 2023 Jan;12(2):1418-1430
pubmed: 35833755
J Exp Med. 2016 Mar 7;213(3):433-49
pubmed: 26880577
Front Oncol. 2021 Mar 11;11:636633
pubmed: 33777792
Leukemia. 2006 May;20(5):777-84
pubmed: 16511515
J Hematol Oncol. 2019 Jun 28;12(1):66
pubmed: 31253180
Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):6001-6
pubmed: 17376872
Mol Cell Biol. 2008 Oct;28(20):6171-81
pubmed: 18710951
Oncogene. 2019 Jan;38(5):687-698
pubmed: 30171262
Cell Stem Cell. 2008 Mar 6;2(3):264-73
pubmed: 18371451
Leukemia. 2017 Sep;31(9):2000-2005
pubmed: 28630438
J Clin Invest. 2009 Apr;119(4):852-64
pubmed: 19287095
Blood Adv. 2019 Dec 23;3(24):4252-4263
pubmed: 31867596
Cancer Cell. 2008 Jun;13(6):483-95
pubmed: 18538732
Cell Cycle. 2008 Nov 1;7(21):3314-9
pubmed: 18948748
Haematologica. 2020 Dec 30;107(1):86-99
pubmed: 33375773
Cancer Cell. 2017 Mar 13;31(3):452-465
pubmed: 28292442
Blood. 2023 Mar 30;141(13):1505-1506
pubmed: 36995706
J Hematol Oncol. 2022 Mar 24;15(1):35
pubmed: 35331314
Haematologica. 2021 Feb 01;106(2):630-634
pubmed: 32381579
Blood. 2013 Apr 25;121(17):3469-72
pubmed: 23407549
Nat Genet. 2017 Mar;49(3):451-456
pubmed: 28112737
Blood. 2020 Dec 17;136(25):2958-2963
pubmed: 33331926
J Biol Chem. 2020 Jul 3;295(27):8887-8900
pubmed: 32434928
Epigenetics. 2021 May;16(5):469-487
pubmed: 32795105
Blood. 2008 Oct 1;112(7):2738-49
pubmed: 18625887
PLoS Genet. 2021 Aug 12;17(8):e1009730
pubmed: 34383740
Leukemia. 2023 Mar;37(3):571-579
pubmed: 36585521
Mol Cell Biol. 2005 Dec;25(23):10235-50
pubmed: 16287841
Nat Cell Biol. 2007 Jul;9(7):804-12
pubmed: 17589499
Nat Commun. 2020 Jul 3;11(1):3339
pubmed: 32620764
Nat Commun. 2019 May 16;10(1):2189
pubmed: 31097698
Expert Rev Hematol. 2019 May;12(5):285-293
pubmed: 30991862
J Med Chem. 2022 Jun 9;65(11):7770-7785
pubmed: 35612819
Blood. 2015 Sep 24;126(13):1575-84
pubmed: 26215111
Blood. 2022 Feb 10;139(6):894-906
pubmed: 34582559
Blood. 2011 Dec 8;118(24):6247-57
pubmed: 21948299
Oncogene. 2016 Oct 6;35(40):5215-5223
pubmed: 26923329
Blood Adv. 2021 Mar 9;5(5):1310-1323
pubmed: 33656539
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Oncotarget. 2018 Jun 1;9(42):26711-26723
pubmed: 29928480
Leukemia. 2009 Aug;23(8):1490-9
pubmed: 19262598
Cancer Cell. 2010 Jun 15;17(6):609-21
pubmed: 20541477
Cancer Cell. 2019 Dec 9;36(6):660-673.e11
pubmed: 31821784
Int J Dev Biol. 2018;62(11-12):847-856
pubmed: 30604854
Leukemia. 2018 Feb;32(2):273-284
pubmed: 28701730
J Clin Invest. 2022 Nov 15;132(22):
pubmed: 36136600
Nat Commun. 2018 May 18;9(1):1983
pubmed: 29777171
Blood. 2020 Nov 12;136(20):2275-2289
pubmed: 32766874
Br J Haematol. 2019 Feb;184(3):337-347
pubmed: 30592296
Front Cell Dev Biol. 2022 Jun 01;10:846092
pubmed: 35721502
Mol Cell Oncol. 2017 Sep 26;4(6):e1345351
pubmed: 29209645
Nat Med. 2015 Apr;21(4):335-43
pubmed: 25822366
Blood Adv. 2018 Oct 9;2(19):2478-2490
pubmed: 30266823
Front Pediatr. 2019 Oct 15;7:401
pubmed: 31681706
Exp Hematol. 2015 Aug;43(8):673-84
pubmed: 26118503
Cancer Res. 2006 Jul 1;66(13):6628-37
pubmed: 16818636
Cold Spring Harb Mol Case Stud. 2021 Apr 8;7(2):
pubmed: 33832921
Elife. 2015 Nov 17;4:
pubmed: 26575292
Nat Genet. 2001 Jul;28(3):220-1
pubmed: 11431691
Genes Dev. 2017 Nov 15;31(22):2222-2234
pubmed: 29269482
Cold Spring Harb Mol Case Stud. 2018 Dec 17;4(6):
pubmed: 30455225
Leukemia. 2017 Oct;31(10):2228-2234
pubmed: 28174417
Blood Adv. 2019 May 14;3(9):1379-1393
pubmed: 31040112
Oncotarget. 2017 Feb 28;8(9):14835-14846
pubmed: 27588400
Pediatr Blood Cancer. 2020 Feb;67(2):e28055
pubmed: 31736254
Nat Genet. 2019 Apr;51(4):694-704
pubmed: 30926971
Leukemia. 2020 Dec;34(12):3173-3185
pubmed: 32591645
Expert Rev Mol Med. 2011 Oct 21;13:e32
pubmed: 22018018
Ann Hematol. 2022 Jul;101(7):1579-1581
pubmed: 35091795
Leukemia. 2021 Dec;35(12):3352-3360
pubmed: 34518645
Blood. 2020 Jul 23;136(4):387-400
pubmed: 32344427
Blood. 2014 Jul 3;124(1):13-23
pubmed: 24764564
Cytometry A. 2021 Aug;99(8):844-850
pubmed: 33811445
J Hematol Oncol. 2021 Mar 20;14(1):47
pubmed: 33743795
Eur J Med Chem. 2021 Dec 15;226:113855
pubmed: 34555614
Int J Biochem Cell Biol. 2010 Dec;42(12):1911-4
pubmed: 20816842
Front Mol Neurosci. 2021 Nov 02;14:767842
pubmed: 34795561
Blood. 1991 Aug 1;78(3):748-52
pubmed: 1859887
Front Pediatr. 2017 Feb 09;5:4
pubmed: 28232907
Nat Genet. 2002 Sep;32(1):148-52
pubmed: 12172547
Blood. 2011 Sep 29;118(13):3645-56
pubmed: 21813447
Genes Cells. 2009 Sep;14(9):1119-31
pubmed: 19682090
Blood. 2016 Jun 30;127(26):3424-30
pubmed: 27114462
Nature. 2009 Jun 11;459(7248):847-51
pubmed: 19430464
Oncotarget. 2016 Jun 28;7(26):39931-39944
pubmed: 27224921
Clin Cancer Res. 2020 Feb 1;26(3):726-737
pubmed: 31719049
Front Immunol. 2021 Feb 22;12:615477
pubmed: 33692789
Front Pharmacol. 2022 Jun 06;13:749472
pubmed: 35734412
Int J Biochem Cell Biol. 2012 Sep;44(9):1444-7
pubmed: 22626970
J Clin Pathol. 2020 Sep;73(9):527-530
pubmed: 32699115
J Hematol Oncol. 2016 Mar 12;9:24
pubmed: 26970896
Mol Cell Biol. 2008 Oct;28(20):6234-47
pubmed: 18710942
Theranostics. 2021 Jul 13;11(17):8172-8184
pubmed: 34373735
Blood. 2021 Mar 25;137(12):1628-1640
pubmed: 33512458
Oncotarget. 2013 Oct;4(10):1712-20
pubmed: 24127550
Nature. 2016 Sep 15;537(7620):369-373
pubmed: 27602518
Int J Mol Sci. 2020 May 12;21(10):
pubmed: 32408494
Blood. 2011 Jun 23;117(25):6895-905
pubmed: 21518926
Blood. 2022 Sep 15;140(11):1200-1228
pubmed: 35767897
Blood. 2015 Feb 5;125(6):941-8
pubmed: 25468569
Leukemia. 2013 Nov;27(11):2165-76
pubmed: 23628958